Apr 24, 2017 - Novo Nordisk has a new hemophilia drug scheduled for an FDA panel review in May.A briefing document published by the FDA views efficacy positively, but brings up safety issues.Despite the fact that pe
Mar 09, 2018 - Two decades ago, the F.D.A. paved the way for an explosion of prescription drug commercials. An episode of “black-ish” offered a worrying example.
Nov 01, 2018 - European stocks were slightly positive on Thursday morning, as investors monitored another batch of earnings results
Aug 08, 2018 - Names on the move ahead of the open.
May 30, 2018 - Names on the move ahead of the open.
Mar 20, 2017 - NVO has had a rough time of it over the past year, for good reasons.These reasons include pricing pressures in the US, decreased multi-year growth projections by management, and management turmoil.Per
Jan 11, 2019 - Johnson & Johnson raised U.S. prices on around two dozen prescription drugs on Thursday, including the psoriasis treatment Stelara, prostate cancer drug Zytiga and blood thinner Xarelto, all among its top-selling products.
Aug 08, 2017 - 70% Equity with 30 Cash + Short Term investments.27 positions including 1 short. Top 10 holdings include: AAPL, GOOG, MSFT, JNJ, NVO, NKE, SBUX, DEO, NSRGY, OKE.Commentary on some recent purchases an
Aug 18, 2017 - Novo Nordisk (NYSE:NVO) needs its once-weekly GLP1 agonist semaglutide to be a smash hit, and a head-to-head win against Lilly's (NYSE:LLY) rival product Trulicity suggests that it could be. FDA appro
Jul 24, 2017 - Fisher’s 13F portfolio value increased from $62.44B to $66.32B in Q2 2017.Amazon.com, Johnson & Johnson, Apple Inc., Visa Inc., and Alibaba Group Holdings are the largest five individual stock positio